Results 81 to 90 of about 178,280 (162)

Thyroid associated orbitopathy with ocular myasthenia in primary hypothyroidism: Keep those eyes open

open access: yesIndian Journal of Endocrinology and Metabolism, 2013
Thyroid associated orbitopathy, although seen most commonly with thyrotoxicosis, is also known to occur in primary hypothyroidism. Myasthenia gravis is an autoimmune condition with an established association with autoimmune thyroid disease. We report the
Chitra Selvan   +11 more
doaj   +1 more source

Myasthenia Gravis and Pregnancy

open access: yes, 2018
Introduction. The combination of myasthenia gravis (MG) and pregnancy has two important aspects: the reflection of the influence of pregnancy on the course of neurological disease and myasthenia influence on the course of pregnancy. Aim.
Nehrych T., Papish M.
core   +1 more source

Prognosis of Ocular Myasthenia Gravis: Retrospective Multicenter Analysis [PDF]

open access: yes, 2015
PURPOSE: To calculate the rate and timing of conversion from ocular myasthenia gravis to generalized myasthenia gravis. DESIGN: Retrospective multicenter analysis. SUBJECTS: Patients included in the study were diagnosed with ocular myasthenia gravis
Abusamra, K   +4 more
core   +1 more source

Ocular myasthenia gravis: case report [PDF]

open access: yes, 2020
Department of Ophthalmology and Optometry, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020Background.
Braicov, Daniela
core   +1 more source

Ocular Myasthenia Gravis and Thymus Gland Hyperplasia–A Case Report

open access: yesTNOA Journal of Ophthalmic Science and Research
Myasthenia gravis (MG) is caused by antibodies directed at acetylcholine receptors or functionally related proteins in the postsynaptic membrane at the neuromuscular junction.
Sujit Das
doaj   +1 more source

Pharmacotherapy of Myasthenia Gravis

open access: yes, 2015
The pharmacotherapy of Myasthenia Gravis is gradually advancing with special regard to immunospuression.
Omar, Majeed
core  

Myasthenia Gravis – a new era of treatment options  [PDF]

open access: yes
Myasthenia Gravis is an autoimmune disease of the neuromuscular junction that causes fluctuating fatigable neuromuscular weakness. The spectrum of severity ranges from mild intermittent ptosis to respiratory failure requiring ventilatory support ...
Jennifer Spillane, Narmathey Thambirajah
core   +1 more source

Neoplasia Associated Ocular Myasthenia Gravis: Primary Renal Tumor in Two Patients with Newly Diagnosed Ocular Myasthenia Gravis

open access: yes, 2006
Poster, "Neoplasia Associated Ocular Myasthenia Gravis: Primary Renal Tumor in Two Patients with Newly Diagnosed Ocular Myasthenia ...
Susan Andracchi
core  

Conversion Rate Of Ocular Myasthenia Gravis To Generalized Myasthenia Gravis

open access: yes, 2013
Ocular myasthenia gravis (OMG) is a common presentation to the neuro-ophthalmology clinic. Previous studies have reported that generalized myasthenia gravis (GMG) develops in 50% or more of patients presenting with OMG, usually within 2 years.
Lina Nagia; Khawla Abusamra; Eric R. Eggenberger
core  

Ocular Myasthenia Gravis: A Case Report

open access: yes
Background: Myasthenia gravis (MG) is an autoimmune disease caused by faulty transmission at the neuromuscular junction leading to fatigable muscular weakness.
Kuiken, Carla Gilbertson, OD   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy